Prostaglandin E2 (PGE2), a byproduct of arachidonic acid metabolism, has been suspected to be involved in tumor promotion. It has been suggested that diet may modulate PGE2 level in organisms thus affecting the implantation and growth of the tumor tissue. PGE2 content was investigated in mice fed ad libitum four types of fatty acid diets: saturated fatty acid diets: a stearic acid and a palmitic acid, and polyunsaturated fatty acid diets: a low fat (safflower 1%) and a high fat diet (safflower 15%). Tumor cells were implanted subcutaneously in mice and harvested when tumors reached .05- 4g. The extracted PGE2 were derivatized and quantified by High Performance Liquid Chromatography (HPLC). The results showed that there is a negative correlation between the level of PGE2 and the size of the tumors. PGE2 level declined as the tumor grew. This suggests that during the early stage of growth the tumor requires higher level of PGE2 to boost its growth. As the tumor becomes more adapted to its environment, it no longer depends on PGE2 to survive. Diet was also seen to be important in tumor suppression. Saturated fatty acid diet (SA-1) showed a suppressive effect on tumor growth. A visual comparison showed that polyunsaturated high fat diet produced more PGE2 than saturated fatty acid. This high level of PGE2 correlate with the highest tumor weights obtained in the Polyunsaturated high fat diet group. / Department of Biology

The specific objective of this study was to determine if Fgf-3 gene expression is mediated by dietary fatty acids and to confirm mouse mammary tumor virus infection. It is well known that dietary linoleic acid enhances growth and dietary stearic acid inhibits growth of mammary tumors. Tumor RNA was extracted from female strain A/St mice fed one of four diets. A radioactively labeled anti-sense RNA probe was generated, invitro, from isolated and purified pFgf-3c (int-2c clone contained in the vector pSP65). The Fgf-3c probe was hybridized to extracted tumor RNA using the ribonuclease protection assay.Electron microscopy confirmed MMTV infection by visualization of type A and B particles in tumor tissue. Expression of Fgf-3c, qualified by RNase protection assay, ranged from 0.02 to 5.89 (relative band density) in all of the diet groups. A positive association between Fgf-3c expression and weight was observed among the tumors of the SA-1 diet (R = 0.947). The SF, SF-1, and PA experimental diets, individually, did not appear to show strong correlation with respect to tumor size. Fgf-3 expression was less in small tumors (<275 mg) and enhanced in large tumors (>275 mg) (p<0.05). / Department of Biology

Dietary fats have been proposed to alter the amount of glucose transporters in various tissues. This study examined how diets containing linoleic or palmitic fatty acids affected the amount of the major insulin-responsive glucose transporter protein, GLUT-4, in red vastus muscle of mice. At 8 weeks of age, 28 healthy female mice were separated into 3 dietary groups, one control group (5% corn oil fat) and two high fat (15% fat) groups. One of the high fat diets was a linoleic acid rich diet (76% linoleic polyunsaturated fat), while the other was a palmitic acid rich diet (95% palmitic saturated fat). The mice remained on their respective diets for 12-13 weeks until sacrifice. Red vastus muscle samples were removed and prepared for GLUT-4 protein analysis. Homogenized red vastus muscle samples were separated by SDSPAGE, transfered to membrane paper, and immunoblotted. scanning densitometry determined the relative quantity of GLUT-4 from each sample. TAP GLUT-4 protein in the group fed the linoleic acid rich diet was 9% higher than the group fed the low fat diet, and 37% higher than the group fed the palmitic acid rich diet. These data suggest that a prolonged high fat diet consisting of linoleic or palmitic fatty acids play a role in the regulation of GLUT-4 protein content. / School of Physical Education

Epidemiological studies have suggested that the consumption of fish may reduce the risk of cardiovascular disease. Compared to the number of studies using fish oils, few studies have used fish itself. Those which have used fish have generally used fattier fish such as mackerel and salmon as part of an uncontrolled diet. In this study, 23 healthy men consumed 200g each of Chinook salmon, Dover sole, and sablefish in a three-way crossover design for 18-day periods with three-week washout periods in between. The diets had the approximate composition of the 'Western' diet: 45% carbohydrates, 36% fat, and 16% protein with the sole diet containing 1.95 g omega-3 (n-3) fatty acids, the salmon diet 3.99 g n-3, and the sablefish diet 3.42 g n-3 fatty acids. Serum total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), bleeding time (BT), blood pressure (BP), platelet aggregation (PA) using ADP and collagen as agonists, platelet fatty acid profiles (FAP), thromboxane B2 (TXB2) , and apolipoprotein B (Apo B) were measured at the beginning and end of each period. TC, and HDL-C, and TG changed significantly when compared to the prefish diet while both LDL-C and apo B demonstrated diet effect. LDL-C increased on both the salmon and sablefish diets (p = 0.08) compared to the sole diet, and increased approximately 15% on the former two diets compared to the prefish diet. Bleeding time was significantly longer when the salmon diet was consumed (p = 0.06). The impact of the three diets on PA depended upon the agonist. With collagen, only the sablefish diet decreased aggregation compared to the prefish diet. When ADP was used, aggregation decreased on both the fattier fish diets compared to the low fat fish (sole). Similar results were demonstrated for TXB₂: the fattier fish produced statistically equivalent decreases (p = 0.06) among the diets, and lowered TXB₂ compared to the prefish diet. There were no significant differences among the diets for either systolic or diastolic BP though there was a significant decrease (p = 0.01) in diastolic pressure compared to the prefish diet when the salmon diet was consumed. Platelet fatty acid profiles reflected diet composition. / Graduation date: 1993

Includes bibliographical references (leaves 237-257). / xx, 257 leaves : ill. ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Investigates the mechanisms underlying the antiarrhythmic effects of omega-3 polyunsaturated fatty acids using adult rat ventricular cardiac myocytes. / Thesis (Ph.D.)--Adelaide University, Dept. of Physiology, 2001

No description available.

Graduation date: 1993

We examined the effect of a functional oil (FctO), with potential weight-controlling and blood lipid-lowering attributes, vs beef tallow as control (C), on the cardiovascular risk profile of overweight women. The FctO comprised energy expenditure-enhancing medium chain triacylglycerols, cholesterol-lowering phytosterols and triacylglycerol-suppressing n-3 fatty acids. In a randomized, single-blind, crossover design, inpatient trial, 17 women consumed each oil as part of a controlled, supervised, energy-adjusted diet for 27 days. Body weight decreased similarly during both dietary periods. Plasma total and LDL cholesterol levels decreased by 4.8% and 10.4% following FctO, and were lower by 9.0% and 16.4% respectively, after FctO vs C. HDL cholesterol and circulating triacylglycerol levels were unaffected by treatment, though HDL:LDL and HDL:total cholesterol ratios increased by 19.5% and 9.4% on FctO. Plasma total homocysteine levels were higher on FctO vs C. Plasma glutathione increased with FctO supplementation. / We conclude that consumption of FctO improves the overall cardiovascular risk profile of overweight women.

No description available.

Arachidonic acid (ARA) and docosahexaenoic acid (DHA) are polyunsaturated fatty acids required for proper embryonic development, specifically neurodevelopment. However, little is known regarding their conversion to other metabolites during embryogenesis. The oxidation of ARA gives rise to the biologically active eicosanoids and the oxidation of DHA gives rise to the biologically active docosanoids. The oxidation of ARA and DHA occurs through enzymatic processes, via lipoxygenase (LOX), or non-enzymatic processes, via radical-mediated lipid peroxidation. We hypothesize that oxidation of ARA and DHA via LOX is required for proper embryonic development. Additionally, we hypothesize that α-tocopherol, a potent lipid soluble antioxidant, mediates the conversion of ARA and DHA to their respective oxidized metabolites. Using zebrafish as a model of vertebrate embryogenesis, we found that the selective knockdown of either 12-LOX or 5-LOX decreased the production of docosanoids, altered fatty acid homeostasis, and increased the incidence of malformations and mortality in embryos by 24 hours post fertilization. α-Tocopherol deficiency also increased the incidence of malformations and mortality during embryogenesis, and in its absence, increased oxidized metabolites of ARA and DHA and decreased fatty acids concentrations. Therefore, oxidized metabolites of ARA and DHA perform crucial functions during embryonic development, but the production of oxidized fatty acids must be balanced with antioxidant bioavailability for proper embryogenesis. / Graduation date: 2012